Dr. Elizabeth A. Dale, MD

Dr. Dale practices at Delaware Valley Medical Management in Bala Cynwyd, Pennsylvania.

Dr. Dale's NPI, 1811218332, was assigned on June 18, 2010. Dr. Dale graduated from Columbia University College of Physicians and Surgeons in 2010. Dr. Dale holds Pennsylvania license MD454366.

Dr. Dale's primary practice is Delaware Valley Medical Management, at 100 Presidential Blvd, Bala Cynwyd, PA 19004 in Montgomery County. The practice phone is (610) 664-2122.

Dr. Dale's primary practice is Delaware Valley Medical Management in Bala Cynwyd, Pennsylvania. Dr. Dale is also affiliated with Wills Eye Hospital. Dmand AI also links Dr. Dale to 4 more medical groups, 3 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dale practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Dale's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Dale's licenses on file in 3 states: Pennsylvania, Florida and New Jersey.

CMS data shows 4,750 Medicare services from Dr. Dale across 20 procedure codes in 2024, for 846 Medicare patients. Medicare paid $332,060 for them.

CMS counts 846 Medicare patients who saw Dr. Dale in 2024. The largest group is 75 to 84, with 356 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dale's median patient age at 76, with 58% women.

In 2024, Dr. Dale wrote 8,602 Medicare Part D claims for 1,334 patients. 68% of them were for generic drugs. CMS names the drug for 8,477 of them, across 31 drugs with 11 or more claims each, at $828,030 in total drug cost. In 2023, CMS named 7,977 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Dale for performance year 2024, reported as part of a group. Dr. Dale accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 145 procedures of cataract surgery by Dr. Dale, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Dale, published from 2011 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Glaucoma, Intraocular Pressure and Glaucoma Drainage Implants. Dr. Dale has published most often in J Glaucoma. Dr. Dale's most frequent co-authors are Michael J. Pro, MD, Marlene R. Moster, MD and Natasha Nayak Kolomeyer, MD.

Dmand AI links Dr. Dale to 1 clinical trial. Conditions studied include Glaucoma, Open-Angle and Glaucoma.

CMS Open Payments shows 162 general payments to Dr. Dale from 27 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Sight Sciences, Inc. paid the most, $24,306.

Dr. Dale graduated from Columbia University College of Physicians and Surgeons in 2010.